Inotiv, Inc. (NOTV)
NASDAQ: NOTV · Real-Time Price · USD
4.280
-0.180 (-4.04%)
Jan 31, 2025, 4:00 PM EST - Market closed
Inotiv Revenue
In the fiscal year ending September 30, 2024, Inotiv had annual revenue of $490.74M, down -14.27%. Inotiv had revenue of $130.42M in the quarter ending September 30, 2024, a decrease of -7.33%.
Revenue (ttm)
$490.74M
Revenue Growth
-14.27%
P/S Ratio
0.23
Revenue / Employee
$236,501
Employees
2,075
Market Cap
144.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 490.74M | -81.69M | -14.27% |
| Sep 30, 2023 | 572.43M | 24.77M | 4.52% |
| Sep 30, 2022 | 547.66M | 458.05M | 511.19% |
| Sep 30, 2021 | 89.61M | 29.14M | 48.18% |
| Sep 30, 2020 | 60.47M | 16.85M | 38.64% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 63.17B |
| AbbVie | 56.33B |
| Novartis AG | 51.72B |
| AstraZeneca | 51.21B |
| Thermo Fisher Scientific | 42.88B |
| Abbott Laboratories | 41.95B |
NOTV News
- 10 days ago - Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025 - GlobeNewsWire
- 4 weeks ago - Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million - GlobeNewsWire
- 5 weeks ago - Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million - GlobeNewsWire
- 6 weeks ago - Inotiv, Inc. Launches Proposed Public Offering of Common Shares - GlobeNewsWire
- 2 months ago - Inotiv, Inc. (NOTV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update - GlobeNewsWire
- 2 months ago - Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - GlobeNewsWire
- 2 months ago - Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024 - GlobeNewsWire